🟢 ACHV is trading 5.9% up today as it rebounds from a recent FDA setback

ACHV is trading at $5.30 (up 5.9%), continuing a recovery following a sharp decline triggered by an FDA decision last week.

• The FDA recently declined to approve Achieve Life Sciences’ smoking-cessation drug, citing issues at a third-party manufacturing site and incomplete labeling requirements.
• With no fresh company-specific headlines on June 24, 2026, the upward move appears to be a technical bounce as investors reassess the severity of the prior selloff.